An institutional filer
Filed with the SEC on · accession 0000886982-26-000443
FOLD filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. An institutional filer submitted an amended Schedule 13G for Amicus Therapeutics (FOLD), indicating a change in passive ownership position.
An institutional filer submitted an amended Schedule 13G for Amicus Therapeutics (FOLD), indicating a change in passive ownership position. The filing text provided does not disclose specific ownership percentages or share counts.
✦ Ask GOAX AI about this filing — what it means for FOLD, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FOLD?
Click hereFOLD filed a SCHEDULE 13G/A (SEC filing). An institutional filer submitted an amended Schedule 13G for Amicus Therapeutics (FOLD), indicating a change in passive ownership position. The filing text provided does not disclose specific ownership percentages or share counts.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Get alerts when FOLD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days